526445 — Indrayani Biotech Balance Sheet

0.000.00%

Last trade - 00:00

Consumer CyclicalsSpeculativeMicro CapContrarian

Annual balance sheet for Indrayani Biotech, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2022 March 31st	2023 March 31st	R2024 March 31st	2025 March 31st	2026 March 31st
Period Length:	12 M	12 M	—	12 M	12 M
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	IAS	IAS	IAS	IAS	IAS
Status:	Final	Final	Final	Final	Preliminary
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	15	127	5.82	2.88	42.6
Net Total Accounts Receivable
Net Total Receivables	154	323	724	1,101	608
Total Inventory
Total Other Current Assets
Total Current Assets	189	775	1,450	1,779	1,587
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	259	479	594	600	636
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	514	1,560	2,340	2,679	2,534
Accounts Payable
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	195	719	871	1,025	930
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Liabilities	272	1,009	1,668	1,954	1,805
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity	242	551	672	725	729
Total Liabilities & Shareholders' Equity	514	1,560	2,340	2,679	2,534
Total Common Shares Outstanding